A26P (p.Ala26Pro) variant of GFAP (Glial fibrillary acidic protein)
A26P (p.Ala26Pro) in GFAP (Glial fibrillary acidic protein) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes population frequency data.
A26P (p.Ala26Pro) variant details
- p.Ala26Pro
- TOPMed rs1231379140
- gnomAD rs1231379140
- Likely benign
- Missense
- Variant Prioritization Score for Impact Estimate 0.569
- CADD 13.30
- PolyPhen-2 0.01
- SIFT 0.17
- EBI: Likely benign
- UniProt: Likely benign
- Most common in the 1KG:MXL population (allele frequency 0.0081)